🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 01/10/1997 | 48,63 | 48,63 | 47,38 | 47,89 | +0,44% | 2,58% | 4.863.139 |
| 30/09/1997 | 48,43 | 48,78 | 47,35 | 47,68 | -1,60% | 2,96% | 5.447.294 |
| 29/09/1997 | 47,68 | 48,69 | 47,41 | 48,46 | +1,44% | 2,69% | 4.269.762 |
| 26/09/1997 | 47,71 | 47,89 | 47,53 | 47,77 | +1,01% | 0,75% | 3.923.502 |
| 25/09/1997 | 47,71 | 48,19 | 46,99 | 47,29 | -2,10% | 2,50% | 5.085.106 |
| 24/09/1997 | 49,56 | 49,92 | 48,28 | 48,31 | -2,53% | 3,31% | 7.153.438 |
| 23/09/1997 | 49,11 | 49,68 | 48,49 | 49,56 | +0,97% | 2,43% | 9.248.390 |
| 22/09/1997 | 47,29 | 49,20 | 47,23 | 49,08 | +4,31% | 4,16% | 9.957.048 |
| 19/09/1997 | 46,34 | 47,17 | 46,10 | 47,05 | +1,41% | 2,32% | 6.730.466 |
| 18/09/1997 | 46,76 | 46,85 | 46,31 | 46,40 | -0,77% | 1,15% | 4.690.219 |
| 17/09/1997 | 46,37 | 46,76 | 46,16 | 46,76 | +1,36% | 1,29% | 5.708.875 |
| 16/09/1997 | 45,15 | 46,37 | 45,03 | 46,13 | +3,20% | 2,97% | 5.703.845 |
| 15/09/1997 | 44,70 | 45,09 | 44,22 | 44,70 | +0,94% | 1,93% | 4.717.886 |
| 12/09/1997 | 44,43 | 44,64 | 43,36 | 44,28 | +0,47% | 2,89% | 7.866.498 |
| 11/09/1997 | 44,07 | 44,43 | 43,57 | 44,07 | -0,07% | 1,96% | 6.130.800 |
| 10/09/1997 | 44,61 | 44,82 | 44,04 | 44,10 | -2,12% | 1,74% | 6.421.306 |
| 09/09/1997 | 44,70 | 45,56 | 44,61 | 45,06 | +0,87% | 2,13% | 4.183.826 |
| 08/09/1997 | 45,92 | 46,01 | 44,55 | 44,67 | -1,96% | 3,18% | 4.141.906 |
| 05/09/1997 | 45,92 | 46,16 | 45,12 | 45,56 | +0,20% | 2,27% | 5.025.579 |
| 04/09/1997 | 45,68 | 46,01 | 45,15 | 45,47 | -0,65% | 1,89% | 4.441.214 |
| 03/09/1997 | 45,65 | 45,98 | 45,21 | 45,77 | +0,26% | 1,70% | 5.210.446 |
| 02/09/1997 | 43,95 | 45,68 | 43,95 | 45,65 | +4,22% | 3,93% | 5.613.507 |
| 29/08/1997 | 43,83 | 44,61 | 43,59 | 43,80 | -0,20% | 2,31% | 5.130.798 |
| 28/08/1997 | 44,07 | 45,03 | 43,57 | 43,89 | -0,94% | 3,32% | 5.799.422 |
| 27/08/1997 | 43,77 | 44,67 | 43,77 | 44,31 | +1,36% | 2,04% | 5.357.586 |
| 26/08/1997 | 44,55 | 44,94 | 43,71 | 43,71 | -2,01% | 2,74% | 4.836.101 |
| 25/08/1997 | 45,32 | 45,56 | 44,37 | 44,61 | -0,93% | 2,63% | 4.244.400 |
| 22/08/1997 | 44,13 | 45,21 | 44,01 | 45,03 | -0,40% | 2,70% | 7.678.067 |
| 21/08/1997 | 45,80 | 45,89 | 44,40 | 45,21 | -1,04% | 3,26% | 4.406.211 |
| 20/08/1997 | 45,44 | 45,83 | 45,26 | 45,68 | +1,06% | 1,25% | 7.219.882 |